162 related articles for article (PubMed ID: 22832898)
1. Multidrug resistance proteins expression in glioma patients with epilepsy.
Calatozzolo C; Pollo B; Botturi A; Dinapoli L; Carosi M; Salmaggi A; Maschio M
J Neurooncol; 2012 Oct; 110(1):129-35. PubMed ID: 22832898
[TBL] [Abstract][Full Text] [Related]
2. Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.
Calatozzolo C; Gelati M; Ciusani E; Sciacca FL; Pollo B; Cajola L; Marras C; Silvani A; Vitellaro-Zuccarello L; Croci D; Boiardi A; Salmaggi A
J Neurooncol; 2005 Sep; 74(2):113-21. PubMed ID: 16193381
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma.
Haga S; Hinoshita E; Ikezaki K; Fukui M; Scheffer GL; Uchiumi T; Kuwano M
Jpn J Cancer Res; 2001 Feb; 92(2):211-9. PubMed ID: 11223551
[TBL] [Abstract][Full Text] [Related]
4. Molecular and functional MDR1-Pgp and MRPs expression in human glioblastoma multiforme cell lines.
Declèves X; Fajac A; Lehmann-Che J; Tardy M; Mercier C; Hurbain I; Laplanche JL; Bernaudin JF; Scherrmann JM
Int J Cancer; 2002 Mar; 98(2):173-80. PubMed ID: 11857404
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic significance of Pgp, MRP1, and MRP3 in ovarian cancer patients].
Sedláková I; Laco J; Tošner J; Špaček J
Ceska Gynekol; 2015 Dec; 80(6):405-13. PubMed ID: 26741154
[TBL] [Abstract][Full Text] [Related]
6. [Expression of ATP-binding Cassette Proteins Pgp, MRP1, and MRP3 in Malignant and Benign Ovarian Lesions].
Sedláková I; Laco J; Tošner J; Špaček J
Klin Onkol; 2016; 29(5):358-363. PubMed ID: 27739315
[TBL] [Abstract][Full Text] [Related]
7. Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy.
Sisodiya SM; Lin WR; Harding BN; Squier MV; Thom M
Brain; 2002 Jan; 125(Pt 1):22-31. PubMed ID: 11834590
[TBL] [Abstract][Full Text] [Related]
8. MRP3: a molecular target for human glioblastoma multiforme immunotherapy.
Kuan CT; Wakiya K; Herndon JE; Lipp ES; Pegram CN; Riggins GJ; Rasheed A; Szafranski SE; McLendon RE; Wikstrand CJ; Bigner DD
BMC Cancer; 2010 Sep; 10():468. PubMed ID: 20809959
[TBL] [Abstract][Full Text] [Related]
9. [Drug resistance proteins LRP, Pgp, MRP1, MRP3 and MRP5 in ovarian cancer patients].
Sedláková I; Laco J; Tošner J; Spaček J; Cermáková E
Ceska Gynekol; 2013 Dec; 78(6):545-53. PubMed ID: 24372433
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of the resistance proteins LRP, Pgp, MRP1, MRP3, and MRP5 in epithelial ovarian cancer.
Sedláková I; Laco J; Caltová K; Červinka M; Tošner J; Řezáč A; Špaček J
Int J Gynecol Cancer; 2015 Feb; 25(2):236-43. PubMed ID: 25594141
[TBL] [Abstract][Full Text] [Related]
11. Differences in the expression pattern of P-glycoprotein and MRP1 in low-grade and high-grade gliomas.
de Faria GP; de Oliveira JA; de Oliveira JG; Romano Sde O; Neto VM; Maia RC
Cancer Invest; 2008 Nov; 26(9):883-9. PubMed ID: 18798065
[TBL] [Abstract][Full Text] [Related]
12. [Expression of proteins associated with multidrug resistance and resistance to chemotherapy in lung cancer].
Paredes Lario A; Blanco García C; Echenique Elizondo M; Lobo C
Arch Bronconeumol; 2007 Sep; 43(9):479-84. PubMed ID: 17919413
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels.
Young LC; Campling BG; Cole SP; Deeley RG; Gerlach JH
Clin Cancer Res; 2001 Jun; 7(6):1798-804. PubMed ID: 11410522
[TBL] [Abstract][Full Text] [Related]
14. [Chemoresistance of CD133(+) tumor stem cells from human brain glioma].
Bi CL; Fang JS; Chen FH; Wang YJ; Wu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):568-73. PubMed ID: 17767043
[TBL] [Abstract][Full Text] [Related]
15. MRP3, BCRP, and P-glycoprotein activities are prognostic factors in adult acute myeloid leukemia.
Benderra Z; Faussat AM; Sayada L; Perrot JY; Tang R; Chaoui D; Morjani H; Marzac C; Marie JP; Legrand O
Clin Cancer Res; 2005 Nov; 11(21):7764-72. PubMed ID: 16278398
[TBL] [Abstract][Full Text] [Related]
16. Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma.
Nies AT; König J; Pfannschmidt M; Klar E; Hofmann WJ; Keppler D
Int J Cancer; 2001 Nov; 94(4):492-9. PubMed ID: 11745434
[TBL] [Abstract][Full Text] [Related]
17. Does a low frequency of P53 and Pgp expression in familial glioma compared to sporadic controls indicate biological differences?
Malmer B; Brännström T; Andersson U; Bergh K; Grönberg H; Henriksson R
Anticancer Res; 2002; 22(6C):3949-54. PubMed ID: 12553017
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance-associated protein MRP1 expression in human gliomas: chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1.
Benyahia B; Huguet S; Declèves X; Mokhtari K; Crinière E; Bernaudin JF; Scherrmann JM; Delattre JY
J Neurooncol; 2004 Jan; 66(1-2):65-70. PubMed ID: 15015771
[TBL] [Abstract][Full Text] [Related]
19. Expression of the multidrug resistance P glycoprotein (Pgp) and multidrug resistance associated protein (MRP1) in Down syndrome brains.
Engidawork E; Roberts JC; Hardmeier R; Scheper RJ; Lubec G
J Neural Transm Suppl; 2001; (61):35-45. PubMed ID: 11771758
[TBL] [Abstract][Full Text] [Related]
20. Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance-associated protein genes.
Jin F; Zhao L; Zhao HY; Guo SG; Feng J; Jiang XB; Zhang SL; Wei YJ; Fu R; Zhao JS
Neuroscience; 2008 Jun; 154(2):541-50. PubMed ID: 18462887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
